APA (7th ed.) Citation

K, v. B., DPC, V., MEJ, v. V., TOAR, M., SM, R., MC, v. Z., . . . JAM, v. L. (2024). Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring. Ocular immunology and inflammation, 32(7), 1268. https://doi.org/10.1080/09273948.2023.2229900

Chicago Style (17th ed.) Citation

K, van Bilsen, et al. "Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring." Ocular Immunology and Inflammation 32, no. 7 (2024): 1268. https://doi.org/10.1080/09273948.2023.2229900.

MLA (9th ed.) Citation

K, van Bilsen, et al. "Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring." Ocular Immunology and Inflammation, vol. 32, no. 7, 2024, p. 1268, https://doi.org/10.1080/09273948.2023.2229900.